Novo Nordisk Adr (NVO)

Feb 20, 2026

Novo Nordisk Stock Investors Just Got Great News From Eli Lilly - The Motley Fool

Feb 20, 2026

Feb 20, 2026

Novo Nordisk stock forecast: Analysts mixed on Q4 earnings & 2026 guidance - Capital.com

Feb 20, 2026

Feb 20, 2026

Glucagon-like Peptide 1 (GLP-1) Market Report 2026-2035: Market to Reach $33.26 Billion by 2030 - GlobeNewswire Inc.

Feb 20, 2026

Feb 18, 2026

Alzheimer's Therapeutics Market Research Report 2026-2036: Growing Global Burden of Alzheimer's Continues to Drive Demand - GlobeNewswire Inc.

Feb 18, 2026

Feb 14, 2026

Novo Nordisk Balances Oral Wegovy Launch With Legal Fight On Compounds - Sahm

Feb 14, 2026

Feb 13, 2026

Novo Nordisk Faces Legal And FDA Challenges As Valuation Gap Widens - Sahm

Feb 13, 2026

Feb 13, 2026

FDA Crackdown Reshapes Wegovy Competition And Risks For Novo Nordisk Investors - Sahm

Feb 13, 2026

Feb 10, 2026

Where is Novo Nordisk A/S (NVO) Headed? - Finviz

Feb 10, 2026

Feb 09, 2026

Novo Nordisk Lawsuit Tests Obesity Drug Patents And Valuation Upside - Sahm

Feb 09, 2026

Feb 08, 2026

Novo Nordisk A/S (NVO) Eyes Solidifying Its Market Position with Increased Advertising Spending - Finviz

Feb 08, 2026

Feb 07, 2026

Jim Cramer on Novo Nordisk: "It Seems Eli Lilly's Eating Their Lunch" - Finviz

Feb 07, 2026

Feb 06, 2026

Novo Nordisk Warning Tests Valuation As Pricing And Competition Intensify - Sahm

Feb 06, 2026

Feb 05, 2026

Ozempic Maker Novo Nordisk Flags Declining Sales In 2026 - Sahm

Feb 05, 2026

Feb 04, 2026

Novo Nordisk Faces a Sales Decline in 2026, But Its Portfolio and Pipeline Provide Long-Term Growth - Morningstar

Feb 04, 2026

Feb 04, 2026

Novo Nordisk Plunges After Releasing a Brutal Forecast. Should You Dump the Stock? - Finviz

Feb 04, 2026

Feb 04, 2026

NVO Q4 Earnings & Sales Beat Estimates, Stock Down on Poor 2026 View - Finviz

Feb 04, 2026

Feb 04, 2026

Novo Nordisk ADR earnings beat by $0.10, revenue topped estimates - Investing.com South Africa

Feb 04, 2026

Feb 03, 2026

Novo Nordisk's U.S. listing drops significantly after earnings report - medwatch.com

Feb 03, 2026

Feb 02, 2026

Novo Nordisk A/S (NVO): A Bull Case Theory - Finviz

Feb 02, 2026

Feb 02, 2026

Jim Cramer Believes Novo Nordisk "Is a Hold, Not a Buy" - Finviz

Feb 02, 2026

Feb 02, 2026

Is Novo Nordisk Stock a Bargain Right Now? - Finviz

Feb 02, 2026

Jan 31, 2026

BMO Raises Novo Nordisk A/S (NVO) Price Target but Flags Prescription Pressures - Finviz

Jan 31, 2026